Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART: Potassium Lowering Drugs and Cardiac Stability in Hemodialysis
NCT06242041Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by Peking University First Hospital. Started Feb 2022; status: recruiting.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT06242041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06242041.